Clinical Trial Update: AYLo - AutoimmunitY and Loss of y

View source ↗

Summary

Clinical trial AYLo from the University of Bonn investigates autoimmunity across multiple diseases and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Connective Tissue Disease
• Giant Cell Arteritis
• Idiopathic Inflammatory Myopathies
• Igg4-related Disease
• Polymyalgia Rheumatica
• Psoriatic Arthritis
• Rheumatoid Arthritis

Snippet

Sponsor: University of Bonn | Conditions: Giant Cell Arteritis (GCA), Polymyalgia Rheumatica (PMR) | Status: RECRUITING